Drug · DIN 02229161
CRIXIVAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 19, 2014; first marketed September 26, 1996.
- Drug Identification Number (DIN)
- 02229161
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Indinavir J05AE02
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INDINAVIR (INDINAVIR SULFATE) | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 8, 2005: NOC 7089New Drug Submission (NDS) · Manufacturer name change
- September 13, 1996: NOC 4467New Drug Submission (NDS)
Other DINs named CRIXIVAN
- DIN 02229188 · Cancelled Pre Market
- DIN 02229196 · Cancelled Post Market